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With approximately a quarter of the one million
HIV-infected individuals in the United States
unaware of their infection,1 increased testing
among high-risk populations has been promoted nationally.2 The importance of providing HIV
testing to prison inmates--a population that generally suffers from a lack of routine community
health care3,4 and for whom the prevalence of
HIV infection is several-fold higher than among
the general population5--has been well documented for nearly 20 years.6-9 Although the
potential individual and societal benefits of testing this high-risk population are substantial,
considerable debate remains about the best
practices for screening prison inmates for HIV
infection. State legislators, public health officials, and prison administrators, among others,
must consider whether HIV testing should be
mandated for all inmates, and if not, the degree
to which consent-based voluntary testing should
be available, encouraged and targeted. HIV
screening policies are implemented on a stateby-state basis and have implications for the protection of inmate rights and for the public health.
In this review, we briefly describe current prisonbased testing practices, summarize issues
raised in the existing debate, and outline possible research and evaluation efforts to help guide
future HIV testing practices in prison.

more timely initiation of care, fewer opportunistic infections, and extended survival.12 Further,
the confines of prison can help facilitate the
receipt of HIV test results compared to community settings where failure to return for test
results is common.13-15 In addition, testing coupled with counseling provides opportunities to
engage inmates in discussions about risk reduction.
For those inmates testing positive for HIV infection, access to healthcare has been affirmed by
the Supreme Court16 and highly active antiretroviral therapy (HAART) is widely available in cor-

rectional settings.17 The effectiveness of HIV
care in prisons has brought about a 75% reduction in AIDS-related mortality,18 a decline mirrorContinued on page 2

Why Test?
The potential benefits of HIV testing for both the
inmates being tested and society at large are
compelling. In contrast to non-incarcerated settings where HIV testing is typically prompted by
illness and provided late in the course of infection,10,11 screening asymptomatic inmates may
allow for earlier diagnosis and consequently
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ing that of non-incarcerated populations.19
Further, the structured environment and the
provision of basic necessities in prison (e.g.
food and shelter) may provide therapeutic
support lacking in some community settings. As discussed in the March 2006
issue of IDCR, ancillary services such as
substance abuse and mental health treatment may also be more readily accessed in
some prisons than in community settings,
further supporting care.
In addition to entering HIV-infected inmates
into treatment, HIV testing programs in
prison have an important role in prevention.
Identification of HIV-infected inmates can
prompt contact tracing, thereby promoting
others to be HIV tested and potentially hindering the spread of the virus within the
community. With studies indicating that
non-incarcerated individuals reduce their
frequency of risk behaviors following HIV
diagnoses,20-22 inmates who are diagnosed
in prison may also reduce HIV transmission
behaviors both in prison and upon returning
to their communities. Among those inmates
who test positive and initiate care, successful maintenance of HAART minimizes
infectiousness by reducing viral load in
genital secretions, further reducing the risk
of transmission.23,24
Negative
Consequences
of
HIV
Diagnosis in Prison
Despite the benefits of HIV testing, there
are also disincentives for inmates to be
tested. Inmates may be reluctant to be
screened for HIV infection because of the
fear that, if positive, information about their
HIV status will disseminate throughout the
prison to correctional staff and other
inmates. The serostatus of HIV-infected
inmates may be intentionally disclosed or,
in the concentrated environment of prisons,
unwittingly revealed by a number of activities associated with HIV care such as
standing in a medication line, attending HIV
specialty clinics, and receiving extra meals
or nutritional supplements.25 The consequences of disclosure among inmates have
not been well documented, but given that

social hierarchies in prison may be reinforced by coerced and consensual sexual
activity, disclosure of HIV status can be
stigmatizing, diminishing social support
and potentially provoking violence or the
threat of violence.25 Institutional consequences of testing positive may include
loss of access to activity programs, visitation, and jobs, as well as housing restrictions.26
In the past, some state prison systems
have segregated HIV-infected prisoners
from the general prison population as a
means to prevent intra-prison transmission.
Policies of segregation have been criticized
for perpetuating stigma, forfeiting confidentiality, and restricting the opportunities (e.g.
for education and work-release) of HIVinfected inmates.25,26 Most agree that these
policies have had little effect on diminishing
already low rates of intra-prison transmission,27 and segregation has now fallen out
of use in all but a few state prison systems.
Some prison systems, however, cluster
HIV-infected inmates in particular facilities.
Clustering of HIV-infected individuals can
facilitate the provision of medical care and
ancillary services. Policies of clustering differ from those of segregation in that they
typically allow for HIV-infected inmates to
live among the general prison population,
which may reduce the consequences of
breaches in confidentiality regarding HIV
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status.27 Criticism of clustering has been
less vocal than that of segregation, and
several state systems that cluster HIVinfected inmates have been noted for
excellence in the provision of HIV care.17
However, like segregation, clustering can in
effect breach inmates' confidentiality and
result in institutional restrictions, such as
those listed above.
Current Prison-Based HIV Testing
Policies
HIV testing policies in many prison systems
(N=29) have been established by their
respective state legislatures.28 In other
states, testing policies have been developed by state health departments or prison
administrators. In both cases, financial considerations--costs of implementing a particular testing policy and providing treatment
and care for identified cases--can play an
important role in determining how HIV
screening is conducted.17,29
Regardless of their policies' origins, state
prison
systems
can
be
broadly
dichotomized into those that mandate HIV
testing for all inmates and those that provide voluntary (i.e. consent-based) testing.
A Bureau of Justice Statistics (BJS) publication reported that for the year 2000, 19
state prison systems employed mandatory
testing at intake; four of these states also
Continued on page 4
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Dear Corrections Colleagues,
An upside of incarceration is the opportunity it affords to conduct critical health screening among
individuals who may have had little prior access to or utilization of basic health care. Evaluation
and testing for conditions that are prevalent among those who are incarcerated - including infections transmitted sexually or via injection drug use - is obviously wise and yields benefits not only
to the individual but also to the communities to which they return. Converging data suggest that
detection of HIV infection earlier rather than later improves clinical outcomes and reduces secondary transmission of the virus, leading many to advocate for broader HIV screening in the
general population as well as in settings with higher prevalence of HIV infection such as jails
and prisons. However, how to effectively and ethically identify inmates who are HIV-infected so
that appropriate care and counseling can be implemented is a challenge states have
approached differently. Unfortunately, there has been little in the way of scientific data to inform
these various approaches.
In this issue, Rosen and colleagues tackle the thorny issue of screening for HIV infection in
prison. They review the available data regarding current screening practices in U.S. prisons and
objectively describe the debate regarding mandatory versus voluntary HIV testing. Their comprehensive and informative article will be valuable to any correctional health care provider
involved in deciding how best to detect HIV in his or her prison system as well as the rest of us
who must live with these decisions. With this review, readers should be able to describe the
major HIV screening methods used in state prisons and their potential advantages and disadvantages.
A real-world perspective on HIV screening is provided by brief reports from Joe Bick and John
May who describe their own experiences screening for HIV infection among inmates in
California and Florida, respectively. These articles are complemented by a guide to HIV counseling and testing prepared by Carol Browning, a nurse at the Rhode Island Department of
Health with extensive experience conducting HIV screening.
The HIV testing debate provokes passionate responses, but informed decision making is called
for. As Rosen and colleagues conclude, more research is needed to identify what works and
what does not and in which setting. The issue of IDCR you hold in your hands (or read on your
screens) was written by experts in this field and, I hope, will provide a balanced view that will
inform your own decisions on how best to effectively and ethically screen for HIV.
As always, please feel free to send letter to the editor, comments and suggestions to me at
wohl@med.unc.edu.
Thanks,

Woodcut print by Eric Avery. M.D. Reprinted with the artist's permission. For more information on Dr. Avery's art
please see http://www.docart.com
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mandated testing upon release.31 The other
31 prison systems implemented voluntary
HIV testing, with most of these systems
providing opportunities for testing upon
entry. At the time of the survey, four state
systems with voluntary testing--Texas,
Florida, New Yorkand California--contained
about half of the nation's known HIV-infected prison population.31
Since the 2000 survey, the Texas32,33 and
Florida34,35 prison systems have changed
testing policies and now mandate HIV testing for all inmates preceding their release;
California is considering such a policy.
Other state systems to change testing policies since 2000 include Michigan, which
switched from voluntary to mandatory testing,36 and Nevada, which switched from
mandatory to voluntary testing34 (see Figure
1 which reflects data from 2003).
Voluntary testing can be offered in many
different ways. In most systems inmates
must request to be tested ("opt-in" testing)
whereas in a few states, inmates are routinely provided testing unless they actively
refuse ("opt-out" testing). Also, testing may
target particular populations: 11 of the 31
systems with voluntary testing in 2000
specifically targeted "high risk" inmates31
(e.g. injection drug users, commercial sex
workers) for HIV testing. As such, prison
systems with policies of voluntary HIV testing encourage testing to different degrees.
Not unexpectedly, the rates of HIV testing
in prisons with voluntary testing vary widely
(39-71%).37,38
Some systems have different testing strategies depending on inmate status. For
example, Rhode Island, which has a single
correctional facility that serves as both the
state's prison and jail, provides routine optout testing to arrestees. If convicted,
inmates who refused testing at arrest
undergo mandatory testing.39 Texas routinely tests inmates as they enter the prison
system and mandates testing of all inmates
upon release.
Regardless of mandatory or voluntary poli-

visit IDCR online at www.IDCRonline.org
cies, most prisons test inmates under the
following circumstances: at an inmate's
request; if clinically indicated; upon involvement in an incident, such as a fight with
blood exposure; and by court order,31 particularly for crimes of a sexual nature and
sometimes for those that involve injection
drug use. Testing under these circumstances, however, likely represents only a
small proportion of all tests performed.
Mandatory HIV Testing
Of all the testing strategies, mandatory testing offers the greatest opportunity to diagnose HIV-infected inmates. The American
Medical Association (AMA) endorsed
mandatory HIV testing of prison inmates in
1987.40 More recently, Braithwaite and
Arriola endorsed mandatory testing for
inmates provided such testing is conducted
in a non-prejudicial manner and adequate
treatment and follow-up resources are
available.41 However, guidelines from the
American Public Health Association
(APHA) suggest that mandatory testing of
inmates is inappropriate, and the World
Health Organization (WHO) deems mandatory HIV testing in prison unethical and ineffective.42,43
Arguing against mandatory testing, critics
cite the inability to preserve confidentiality
in prison25 and the discrimination and
stigmatization that HIV-infected prisoners
have historically endured, particularly as a
result of segregation.26 Further, some feel
that mandatory testing diminishes inmates'
opportunities to engage in thoughtful counseling about risk behaviors since testing will
be conducted regardless of whether an
inmate deems it necessary.44
A study by Varghese and Peterman projected the number of HIV cases averted by
providing counseling and testing (CT) in
prison.45 The results indicated that in lowprevalence settings (<1%), the majority of
averted cases (80%) resulted from
seronegative inmates reducing their likelihood of acquiring HIV following CT; only
20% of cases were averted because newly
diagnosed inmates reduced their potential
risk of transmission following CT. Although
this study was based on a number of
assumptions, it implied that in prisons with
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a low prevalence of HIV, prisons requiring
mandatory testing without (or with insufficient) counseling might be less effective at
averting future cases of HIV than prisons
that provide widespread counseling. It is
noteworthy that in 2003, 13 of the 20 prison
systems with mandatory testing had prevalence estimates of 1% or less.34,46
Voluntary "Opt-In" HIV Testing
Voluntary testing wherein the individual
must consent (i.e. opt in) to HIV testing may
preserve inmates' autonomy, but existing
literature, though dated, suggests that a
substantial proportion of infected inmates
remain undetected in systems with voluntary testing. Rates of HIV infection determined by seroprevalence studies exceeded
rates of infection determined by voluntary
testing in the Maryland, California, Illinois,
New Jersey47 Wisconsin48 and Oregon49
state prison systems. Studies in the
Maryland50 and Wisconsin48 state prison
systems, for example, reported that rates of
HIV infection among those tested in blinded
studies were twice that of volunteer testers.
In Wisconsin, 31% (8/26) of all HIV-infected
inmates declined to be tested, and in
Maryland 66% (134/204) of all HIV-infected
inmates declined testing.
Unlike testing for other communicable
infections, before testing for HIV infection,
healthcare providers are required to counsel patients about risk behaviors and obtain
written informed consent. Although these
procedures were initiated to lessen potential, negative psychosocial repercussions of
testing HIV-positive, some argue that they
create undue obstacles for testing, including additional time spent conducting the
counseling and paperwork. Further,
because the written consent process is
unique to HIV, it may in fact further perpetuate stigma associated with being tested.51
Additionally, identification of patients at risk
for HIV infection who should be offered
testing can be challenging. Patients are
often reluctant to disclose behaviors related
to transmission, and providers can be poor
at eliciting information about these behaviors. Although approximately one-third of
state prison systems with voluntary testing
Continued on page 5
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specifically target "high risk" inmates, the
definition of "high risk" has not been well
defined and likely varies across, and perhaps within, state prison systems. Several
studies have identified factors associated
with HIV infection among inmates, but the
extent that these factors have been used to
screen inmates--and their ability to identify
new infections--has not, to our knowledge,
been documented. Without validation, targeted testing may divert prevention and
testing resources away from inmates at risk
for infection.
Routine or Voluntary "Opt-Out" Testing
Recommendations for routine testing, both
in community and correctional populations,
have been gaining support over the last
several years.51,17,52 In community settings,
the proportion of those tested as a routine
part of medical care is on the rise.53 The
CDC's revised HIV testing guidelines,
released in 2001, and its 2003 initiative,
"Advancing HIV Prevention," both recommend that routine testing be offered in settings with prevalence estimates of >1%,
including correctional settings that fit this
prevalence criterion.2,54 A technical addendum to the 2003 initiative recommends routine testing in prisons without reference to
the 1% prevalence cut-off.55
Unlike voluntary opt-in testing, routine optout testing (i.e. conducting HIV screening
unless the individual refuses to be tested)
does not depend on patients' self-disclosure of risky behaviors. It may help to normalize the testing process and decrease
test-associated stigma, increasing acceptance of offered testing and potentially
increasing new diagnoses. To further promote acceptability, some suggest that routine testing should be offered with minimal
pre-test counseling; extensive counseling

visit IDCR online at www.IDCRonline.org
and services would be available for those
testing positive.51
The provision of routine HIV testing in the
Rhode Island Department of Corrections
has had a substantial impact on detecting
infected individuals in that state. From
1989-1999, diagnoses among prison
inmates constituted 33% of all new HIV
diagnoses in Rhode Island.39 While this proportion includes convicted inmates who
undergo mandatory testing, 90% of
inmates accepted routine testing upon
entry.17
Some inmate advocates suggest that optout testing conducted in prison, an inherently punitive environment, is coercive by
nature and akin to mandatory testing.56
Corrections-based providers in Rhode
Island counter that testing is not coercive,
but rather is well-accepted among inmates
because it is coupled with comprehensive,
prison-based treatment programs.52 In support of this argument, a study of released
Rhode Island inmates found that 77% of
respondents endorsed HIV testing.57
Despite most respondents' endorsement of
testing, the high rates of acceptance raise
questions about inmates' autonomy; in two
community-based studies of routine HIV
testing, acceptance rates were 37%58 and
40%,59 well below the 90% acceptance
rates among Rhode Island inmates.
However, in the Texas correctional system,
which incarcerates more inmates than any
other system in the United States,46 refusal
of routine testing at intake has been reported as less than 1%.32
Future Research and Evaluation of HIV
Testing Policies
A variety of HIV testing policies are practiced in state prisons across the U.S. Each
of these policies appears to have different
implications for the protection of inmate
rights (i.e. autonomy, confidentiality, and
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access to care) and for prevention of disease transmission in community settings.
However, our understanding of these different policies is incomplete, based on anecdotal information and extrapolated from
non-prison populations. The application of
similar polices may vary greatly by state
prison system and by prison. To truly evaluate these programs in regard to their
impact on inmate rights and public health,
we propose that the following areas be
assessed:
Congruity between testing policies and
their applications
Costs of testing, counseling and prevention programs
Inmate, provider and system charactecistics associated with uptake of
HIV testing in systems with voluntary
testing
Efficacy of counseling on the acceptance of HIV testing and the reduction of
inmate risk behaviors
The roles of confidentiality and stigma in
acceptance of testing
Psychosocial and physical (e.g. disease-related morbidity, target of assault)
consequences of testing positive in
prison
Utility of targeted testing
Availability of and access to services following release
To our knowledge, only the last of these
areas has received any attention. These
evaluations could be couched as part of
larger assessments of medical care in
prison. Although there is certainly a disincentive for prisons to document their own
lapses in care, a necessary first step to
improving medical care and promoting public health through the prison system is to
take a sober look at the services provided.
Prison health care experts should work with
governmental agencies to develop and
implement these evaluations.
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IN

CORRECTIONAL SETTINGS: A TALE

HIV TESTING WITHIN THE CALIFORNIA DEPARTMENT
CHALLENGES, SUCCESSES, AND LESSONS LEARNED
Joseph Bick, MD
Chief Medical Officer, California Medical
Facility, California Department of Corrections

The California Department of Corrections
and Rehabilitation (CDCR) is the largest
criminal justice system in this country, with
more than 168,000 inmates and another
140,000 on parole.1 The CDCR currently
does not routinely mandate HIV testing of
all inmates. Specific situations in which HIV
testing is required include when the commitment offense involves certain sex crimes
and/or the inmate has been responsible for
causing the transmission of blood or other
body fluids on, upon, or through the skin or
mucous membranes of another person. A
bill currently under debate in the California
State Assembly would require the CDCR to
test all paroling inmates for HIV at some
point in the 60 days before their release.2
Blinded serostudies of blood collected from
incoming CDCR prisoners were performed
by the California Department of Health
Services in 1996 and 1999, yielding HIV
seroprevalence rates of 1.5 and 2.5%,
respectively.3 Applying these prevalence
data to today's population would yield
between 2,500-4,300 HIV-infected persons
among the 168,000 individuals who are
currently incarcerated. By contrast, the
CDCR is aware of only approximately
1,300 HIV-infected prisoners. It is not clear
how many of these patients do not know
their HIV status as opposed to those who
are aware but do not disclose this information to prison medical staff. Numerous serious disincentives to divulging HIV status
exist within the CDCR including:
Restrictions on job assignments
Limitations on potential housing sites
Decreased educational opportunities
Prolonged sentences if restricted from
work-release programs
A prohibition against conjugal visiting
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CORRECTIONS:

Different punishments for in-custody
infractions (those who are known to be
HIV-infected are subject to harsher punishments if they are found guilty of
being involved in the willful exchange of
body fluids.)

cers when an HIV-infected inmate is
released.

Furthermore, there are a plethora of laws in
California that may serve to dissuade individuals from disclosing their HIV status.4
Among these are:

Currently the CDCR encourages voluntary
HIV testing of all at-risk inmates. However,
it is clear that many inmates do not request
or accept this testing and others do not
have it offered to them. As a result, many of
those who are HIV-infected do not benefit
from earlier diagnosis and treatment - welldescribed to improve outcomes.5,6 In
California, pre-test counseling and
informed consent are required by HSC
120990. One recent study within the CDCR
demonstrated that offering routine, one-toone HIV counseling to all incoming inmates
doubled the acceptance of voluntary HIV
testing.7 This study also concluded that a
significant percentage of high-risk individuals had never previously been tested for
HIV, and that offering multiple testing
modalities (blood, urine, oral fluid) can
increase the number of individuals who
choose to test. A follow-up study is being
undertaken to further evaluate those who
elect to not test to identify information that
may be useful in improving the number of
inmates who elect to learn their HIV
serostatus.

Health and Safety Code (HSC) 121015:
Permits a treating physician to disclose a
person's HIV status to a spouse and any
person reasonably believed to be the sexual or needle-sharing partner of the individual.
HSC 120291: States that if an individual is
known to know that he/she is HIV-infected
and engages in unprotected sex, he/she
can be charged with a felony.
HSC 121070: Requires medical personnel
to disclose the HIV status of all inmates to
the "officer in charge" of the detention facility who is then required to notify all employees and volunteers who may have direct
contact with the inmate.
Penal code (PC) 12022.85: Increases by
three years the sentence of those convicted
of rape, unlawful sodomy or oral copulation
if the defendant knew he was HIV-infected
at the time of the offense.
PC 1202.6: Requires those convicted of
prostitution to be tested for HIV.
PC 647: Elevates any subsequent prostitution conviction among those known to be
HIV-infected from a misdemeanor to a
felony.
PC 7520: Directs correctional officials that
they must notify parole and probation offi-

PC 7521: Allows parole and probation officers to inform the spouse of paroling
inmates of their HIV status.

Clearly, there is a need to minimize the disincentives that currently exist for HIV testing and disclosure of HIV seropositivity
within the correctional setting. Those diagnosed earlier in the course of infection may
be more likely to prevent the development
of opportunistic infections and malignancies, and less likely to transmit infection to
others. Improving the number of inmates
who voluntarily test for HIV has the potential to benefit both inmates and the communities to which most of them will one day
return.

BROWARD COUNTY JAIL, FLORIDA

John P. May, MD
Armor Correctional Health Services
Mark Welch, Medical Student
NOVA Southeastern College of Osteopathic
Medicine
Rosemary Jackson, MD, MPH
Medical Director, Broward County Jail, Armor
Correctional Health Services

The Broward County Jail in South Florida is

one of four nationwide sites participating in
a Centers for Disease Control and
Prevention (CDC) demonstration project,
Rapid HIV Testing of Inmates in Short Stay
Correctional Facilities. The RAPID
(Reducing AIDS Prevalence in Detention)
Project is a collaborative effort between the
Broward County Health Department, the
Florida Department of Health, the Broward
Sheriff's Office, and Armor Correctional
Health Services. The RAPID team, a staff of
four, provides voluntary rapid HIV testing

utilizing the OraQuick HIV-1/2 test kit, prevention counseling, and referrals to postrelease care and services to Broward
County jail inmates. The opportunity for voluntary HIV testing and counseling is provided at no charge to inmates during the initial
health assessment or by request through
sick call. Individuals who test positive for
HIV infection receive post-test counseling,
medical treatment, preventive health care,
transmission prevention counseling, and
Continued on page 7
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(continued from page 6)
are linked to case management and discharge planning through the health department's on-site Jail Release Linkage Project.
The project began testing in January 2004.
As of March 2006, the RAPID team had
provided testing and counseling to more
than 10,000 inmates. Most of those
approached agreed to the HIV screening
and many inmates reported that they would
not have gotten tested if they had not been
offered the test in jail or if they would have
had to return for the results.
A medical and correctional record review
was conducted of persons newly identified
as HIV-infected through the RAPID Project
from March 2004 through April 2005. During
the 13 month period, 62 (0.8%) previously
unknown HIV infections were found among
7,403 tested. The average age of those
infected was 35.8 years (range 20-64).
Those newly identified had an average of
6.7 prior incarcerations, with a range of 124 prior admissions to the jail. The criminal
charges of inmates newly identified with
HIV were drug offenses (41%); violations of
probation (25%); many related to illicit substance use; theft or burglary (14%); assault

(9%); or other (11%). Most (72%) were
released from the jail on a bond, probation,
or time-served sentence. Some (23%) were
transferred to a state prison or another jail
facility. Five percent were admitted to a
court-ordered drug-treatment program.
The average length of stay for those newly
identified was 81 days, although most
(53%) were released in less than 30 days
after their test result. Latent tuberculosis
infection was present in 20% of the patients.
Because of the limited length of stay for
most inmates, many were released from the
jail before completing their comprehensive
health assessment and laboratory testing.
Of those remaining in the jail long enough to
complete the laboratory testing, one third
(33%) had CD4+ T-cell counts less than
200 cells/mm3. Of these, and others eligible
for antiretroviral treatment based on clinical
criteria, few (6 patients) remained in the jail
long enough to initiate a program of antiretroviral treatment. None of the newly identified patients required hospitalization during the review period. On the other hand,
one inmate who chose not to have HIV testing and with no known history of HIV was
hospitalized for an extended period and
found to have HIV infection and disseminated tuberculosis.
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4
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HIV 101: PREVENTION COUNSELING , TESTING
Carol A. Browning*, MS, RN, BC
Rhode Island Department of Health's Office of HIV and AIDS

The RAPID HIV testing project is enormously successful at the Broward County
Jail. The dedication and skill of the health
department and on-site staff, the support of
the jail leadership, and the funding and collaboration from public and private agencies
facilitates its success. The project identifies
many who would otherwise not be aware of
their HIV infection, including some with
advanced HIV disease, and connects these
individuals to medical treatment, transmission prevention counseling, and case management. While many are arrested on drugrelated offenses and the criminal court
directs few to drug treatment, health department linkage to post-release medical care
provides an opportunity for further intervention and treatment. Collateral costs of the
project, such as on-site medical evaluations, laboratory tests, and antiretroviral
treatments are not prohibitive, in part
because of the limited length of stay, but
also because early intervention and treatment is cost-effective particularly if hospitalizations are avoided. Because of the high
rate of turnover in a jail population, rapid
testing is an effective method to reach many
at-risk individuals, bring care and treatment
to those in need, and deliver prevention
messages.

AND

REFERRAL

HIV Prevention Counseling and Testing is routinely recommended
for all clients in settings where the population is at increased behavioral or clinical risk for acquiring or transmitting HIV infection,

*Nothing to Disclose

Continued on page 8

Stepwise Approach to HIV Counseling, Testing and Referral3
PRESTEST SESSION
1. Introduce yourself to the client.
Hello my name is Mary and I will be talking with you today about your risks and
concerns regarding HIV.

2. Explain the role of the counselor.
I will be working with you to help determine your risk of HIV infection from any
previous risky behavior as well as your risk of getting infected with HIV in the
future.
3. Indicate the duration and content of the session.
You will probably be here about 20-40 minutes.
We will talk about the HIV test itself and what it means. We will see whether you
will need to have another test because of any recent risky exposure you may
have had that would not be picked up by the test today. Counseling regarding
the nature of the HIV antibody test and the so called 'window period' between
exposure and detection of HIV antibodies may be appropriate to discuss.
Discuss procedure for notification of the inmate of the test result and who else
will be notified of the result.
Describe whether information discussed will be confidential and any limits of that
confidentiality.

4. Explore HIV and STD risks.
If you were infected, how do you think you may have gotten infected?
5. Identify challenges to risk reduction.
What do you think may have kept you from protecting yourself at the time you
had unsafe sex/shot drugs?
6. Discuss strategies to risk reduction.
How would you most like to reduce your risk for HIV?
Tell me how you feel you could go about making the change?
7. Provide referrals.
Who in your life do you feel is supportive of you?
Would you feel comfortable talking to someone about your risks and how to
change your risks?
8. Address immediate questions and concerns.
What other concerns do you have before you leave today?
Provide information regarding who the inmate should contact if he/she has any
other questions after the session.
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Additionally, providers must be willing to stay current on new counseling techniques and testing technology. Below is an abridged
guide for assisting providers in providing a client-centered counseling session. An example of a statement/technique is provided for
each step. For more thorough guidelines, please refer to the CDC
Recommendations issued in 2001.1

(continued from page 7)
regardless of setting prevalence.1 HIV Prevention Counseling seeks
to reduce HIV acquisition and transmission. Field specialists have
identified skills and counselor characteristics that are important for
effective HIV Prevention Counseling.2 These skills and characteristics include some of the following:

Although it is unlikely that a single episode of HIV Prevention
Counseling will result in the immediate and permanent adoption of
safer behaviors,4 client-centered HIV counseling and attendant prevention services (i.e. referral and partner notification) do contribute
to the initiation and maintenance of safer behaviors. By utilizing the
above steps, high-risk behaviors (and the potential for transmission)
are more likely to decline when a patient undergoes personalized,
interactive counseling rather than a didactic, information approach.5

Belief that counseling can make a difference
Active listening skills
Ability to use open-ended rather than closed-ended questions
Ability to provide a supportive atmosphere to allow trust to be
built
Comfort in discussing specific HIV risk behaviors (i.e. explicit
sex or drug behaviors)
PROVIDING NEGATIVE RESULTS

PROVIDING POSITIVE RESULTS

1. Welcome the client back.
My name is Mary, you may remember from last time. Come in and
have a seat.

1. Welcome the client back.
My name is Mary, you may remember from last time. Come in and
have a seat.

2. State results clearly and simply.
Your test result is negative, which means that the test did not detect
evidence of HIV infection in your blood.

2. State results clearly and simply.
Your test result is positive, which means that at some point in your
past you have been infected with HIV.

3. Review the meaning of the results.
This negative result means that you did not get infected with HIV
from anything that happened to you within the past 3 to 6 months.

3. Allow the client time to absorb the tests results.
Counselor may want to sit quietly with the client at this time.
4. Review the meaning of the results.
This positive result means you have HIV, not necessarily that you
have AIDS. Other tests can help you and your doctors understand
more about the infection.

4. Assess the client's reaction to the result.
What are you feeling about your negative test result?
5. Note the need to retest for any recent risk behavior.
1) For the inmate who has had a recent risk (< 3 to 6
months):
You mentioned last time you had a recent exposure. You
may want to consider another test 3 months from that
high-risk exposure; or,

5. Assess the client's reaction to the result.
How had you thought the results would come back?
Is the result surprising to you?
6. Recognize the challenges of dealing with a positive result.
What is the most difficult thing for you to deal with right now?

2) For the inmate who has had a risk greater than 3 to 6
months ago:
From your last session, I recall that your exposure was
more than 3 to 6 months ago, therefore, you do not need
to be tested again for that exposure.

In addition to the above points consider the following where
applicable:
1. Assess whom the client plans to tell of the results.
Do you want to tell those who care about you?
Who you can trust?
How do you think they will respond?
I will write down some support agencies that you may find helpful
(if applicable).

In addition to the above points consider the following where
applicable:
1. Assess the client's readiness to make efforts toward safer
behavior.
Let's talk about the plan that you made last week.
Do you plan to use condoms/clean needles, talk to your partner
about being safe, etc?
How do you continue to remain negative for HIV?

2. Review medical care available and identify medical care in
community if inmate about to be released.
Where do you go for medical care? (if applicable)
What do you think about going to see a specialist (provide
name)?

2. Provide encouragement and support for efforts.
It's great you were able to consider talking to your partner about
being safe.
Sounds like you made a healthy change for you.

3. Identify need for referrals.
What is the most important thing for you to deal with first?
What other things do you need help with?
Do you have concerns about housing, medical issues or insurance after you are released (if applicable)?

3. Identify benefits/barriers to the risk-reduction plan.
What will work best for you?
What would make it easier for you?
What is challenging to do?
References:
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SAVE THE
DATES
Satellite Videoconference
"Hepatitis B & C with HIV
Co-infection"
April 19, 2006
12:30-2:30 EST
CME-accredited webstream of
last conference available online
Visit: www.amc.edu/patirnt/hiv
/hivconf/index.htm
17th International
Conference on the
Reduction of Drug Related
Harm
April 30-May 4, 2006
Vancouver, British Columbia,
Canada
Visit: http://www.harmreduction2006.ca/
American Correctional
Health Services Association
Conference
May 11-13, 2006
Durham, NC
Visit:http://www.achsa.org/displaycommon.cfm?an=4
Society of Correctional
Physicians Semiannual
Meeting
May 13, 2006
Durham, NC
Visit:http://www.corrdocs.org/e
vents/events.html
Understanding Our Patients:
HIV and Women in
Corrections
June 16, 2006
Moody Gardens Resort and
Conference Center
Galveston, Texas
International Prisoner
Health: Achieving
International Standards in
Prison Health Care
June 19-20, 2006
Tallinn, Estonia
Visit:http://www.tandfevents.co
m/prisonerhealth
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Prior, unprotected sex with multiple partners
among young, incarcerated men
Margolis et al. surveyed 550 men (mean age 23 years,
range 18-29) in California, Mississippi, Rhode Island and
Wisconsin state prisons about their HIV/STD risk behaviors prior to incarceration to identify factors associated
with the men's engaging in unprotected vaginal or anal
sex with two or more partners ("multiple partners") in the
three months prior to incarceration. Men were asked
about their sexual activity, condom use and perception
of risk during the three months prior to incarceration,
with two types of partners: "main" (defined as having a
special emotional commitment) and "casual" (defined as
lacking a feeling of commitment). They were also asked
about their history of alcohol and drug use, housing status (with stable housing defined as living in a house or
apartment that the participant or his friend rented),
employment, access to healthcare services, and
involvement in organized religion.
Seventy-one percent of the men reported multiple sex
partners and 45% (n=249) reported having unprotected
sex with multiple partners. These 249 men constituted
53% of the cohort with a prior STD diagnosis and 57%
who reported having a "risky" sexual partner (defined as
someone they believed to have used crack, injected
drugs, traded sex for drugs or money, had multiple sex
partners or been infected with HIV or an STD).
Participants had engaged in vaginal (98%) and anal
(46%) sex.
Multivariate analyses indicated that men who reported
having a high-risk sexual partner or having drunk five or
more alcoholic beverages at least once per week were
more likely to have engaged in unprotected sex with two
or more partners. By contrast, men who reported having
stable housing or having participated in organized religion were less likely to have engaged in unprotected sex
with multiple partners. The authors laud prisons that
have opened their doors to community-based organizations, creating linkages to preventive health programs as
well as a continuity of care that extends from the period
of incarceration through the men's transitions back to
their communities.
Margolis AD, MacGowan RJ, Grinstead O, Sosman J, Kashif I,
Flanigan TP, and the Project Start Study Group. Unprotected
Sex With Multiple Partners: Implications for HIV
Prevention Among Young Men With a History of Incarceration.
Sexually Transmitted Diseases 2006;33(3):175-80.

Sexual Activity of HIV-Infected
Recently Released from Prison

Persons

To investigate sexual HIV transmission risk behaviors
among HIV-infected state prison inmates prior to and
after incarceration, Stephenson and colleagues interviewed soon-to-be-released, HIV-infected North
Carolina State prison inmates both before and after their
release. Researchers administered qualitative and
quantitative questionnaires to the inmates both prerelease (face-to-face) and an average of 45 days postrelease (via telephone). The questionnaires addressed

CDC Guidelines Related to HIV
http://www.cdc.gov/hiv/resources/guidelines/index.htm
CDC Guidelines for Rapid HIV Testing
http://www.cdc.gov/hiv/rapid_testing/index.htm
CDC Routine HIV Testing of Inmates in Correctional Facilities
http://www.cdc.gov/hiv/topics/prev_prog/AHP/resources/guidelines/Interim
_RoutineTest.htm
CDC Demonstration Projects for State and Local Health
Departments: Routine Rapid HIV Testing of Inmates in Short-Stay
Correctional Facilities. October 2004.
http://www.cdc.gov/hiv/topics/prev_prog/AHP/resources/factsheets/Correct
ional_Facilities.htm

sexual activity, number and types of sexual partners,
condom use, HIV disclosure to sexual partners, beliefs
about HIV transmission, and substance use during sexual relations.
Prior to release, 86 participants (57% women, 74%
African-American, 83% heterosexual, 77% unmarried,
76% diagnosed with HIV infection prior to this incarceration, mean sentence duration of 416 days) were interviewed. In the year prior to their incarceration, all had
been sexually active and the mean number of partners
was eight. Condom use varied by sex act; 22% of those
engaging in penile-vaginal sex and 42% and 14%,
respectively, of the seven men and seven women who
had receptive anal intercourse reported not using condoms during this period.
Following release, 64 (75%) of the participants were reinterviewed a mean of 45 days after release. The
remaining participants were lost to follow-up, re-incarcerated, dead or had dropped out of the study. Following
their release from prison, almost half (47%) of the participants were sexually active within an average of 11
days (range 1 hour to 60 days post release). Ninety percent of these sexually active participants had a "regular"
(i.e. main) partner and 86% had sex exclusively with
their regular partners. Of those with a regular partner,
81% returned to the same partner they had prior to
incarceration. Only one releasee had both a regular and
non-regular partner, and only two participants (3%)
reported having a new sexual partner after their release.
Condom use was less likely during sex with a regular
partner than with a more casual partner; 26% of those
with a regular partner had sex with that partner without
using a condom while all of those with non-regular partners used condoms during sex with these individuals.
More than half of sexually active participants believed
their partners to be HIV-uninfected, and of those who
were sexually active, 31% believed it was "somewhat" or
"very" likely they would eventually infect their HIV-uninfected partner. Post-release, 79% of sexually active participants reported an increase in condom use following
release and 97% of releasees reported disclosure of
their HIV status to their current sexual partners.
These results suggest that a significant proportion of
HIV-infected individuals engage in unsafe sex while nonincarcerated, particularly with their main or regular partners. However, self-reported disclosure of HIV status to
partners was high and condom use reportedly increased
following incarceration, suggesting that in-prison counseling may have been at least partially effective. The
authors recommend enhancement of testing and counseling, including the development of prevention interventions that can span the period between incarceration
and release.
Stephenson BL, Wohl DA, McKaig R, Golin CE, Shain L,
Adamian M, Emrick C, Strauss RP, Fogel C, Kaplan AH. Sexual
behaviours of HIV-seropositive men and women following
release from prison. Int J STD AIDS. 2006;17(2):103-8.

HIV Care in Corrections. Dr. Douglas Fish, Head of Division of HIV
Medicine, Albany Medical College
http://www.nynjaetc.org/curriculum/Corrections.ppt
Videos Pertaining to HIV Testing in Correctional Settings
Available at:http://www.aids-ed.org/aidsetc?page=et-30-36
HIV Transmission and Prevention in Prisons
Dr. Elizabeth Kantor, University of California-San Francisco
http://hivinsite.ucsf.edu/InSite?page=kb-07-04-13
International AIDS Society-USA: Webcasts and Podcasts
http://www.iasusa.org/webcast/index.html
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Brown Medical School designates this educational activity for one hour in category one credit toward the AMA Physician’s Recognition
Award. To be eligible for CME credit, answer the questions below by circling the letter next to the correct answer to each of the questions.
A minimum of 70% of the questions must be answered correctly. This activity is eligible for CME credit through February 28, 2006.
The estimated time for completion of this activity is one hour and there is no fee for participation.

1. The potential benefits that follow the diagnosis of HIV infec
tion among the incarcerated include each of the following
EXCEPT:
A. Opportunity to initiate medical care to prevent opportunistic infections and HIV disease progression
B. Prevention counseling
C. Referral to community based services prior to release
D. Permits correctional staff to identify which patients to
examine only while wearing gloves
2. Each of the following organizations opposes mandatory HIV
testing of inmates EXCEPT:
A. American Medical Association (AMA)
B. World Health Organization (WHO)
C. American Public Health Association (APHA)
D. None of the above
3. Which of the following statements regarding voluntary HIV
testing are TRUE:
A. Opt-in testing entails the individual providing informed
consent to be tested
B. With opt-out testing the individual will be tested unless
he or she requests that the test not be performed
C. The majority of state prisons in the US provide voluntary
HIV testing to entering inmates
D. A and B
E. A, B and C
4. As described by Rosen et al., criticism of voluntary HIV testing
for inmates includes:
A. In some state prisons, HIV prevalence rates detected
through voluntary testing programs were lower than
prevalence rates found in blinded seroprevalence studies.
B. The required pre-test counseling and consent process
create an undue obstacle to testing and may perpetuate
stigma associated with HIV.
C. Voluntary HIV testing affords inmates less confidentiality
as compared to mandatory testing.
D. A and B
E. A, B and C

5. In most prisons, inmates diagnosed with HIV infection are
segregated in specialized facilities (TRUE or FALSE)?
A. True
B. False
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